A 177Lu Bone Microenvironment–Targeted Radiopharmaceutical with Integrated Tumor Suppression, Bone Protection, and Pain Relief Across Osteolytic and Osteoblastic Bone Metastases

Prolia (denosumab) - Amgen

BPR-6023021 - Chengdu Brilliant Pharma

zoledronic acid - Generic mfg.

Yunkou Wu; Huan He; Xiaoping Fu; Jing Wen; Wanjiao Gao; Wei Yang; Tonghui Chen; Jianyu Liao; Jiachuan Duan; Shengjun Fan; Haoxi Huang

May 26, 2026